Literature DB >> 11853543

Effect of brefeldin A on heparan sulphate biosynthesis in Madin-Darby canine kidney cells.

Svein Olav Kolset1, Kristian Prydz, Katja Fjeldstad, Fariba Safaiyan, Tram Thu Vuong, Eva Gottfridsson, Markku Salmivirta.   

Abstract

Brefeldin A (BFA) perturbs the organization of the Golgi apparatus, such that Golgi stack components are fused with the endoplasmic reticulum (ER) and separated from the trans-Golgi network. In many cell types, BFA blocks the secretion of macromolecules but still allows the action of Golgi enzymes in the ER. Treatment of cells with BFA has been reported to inhibit the secretion of heparan sulphate (HS) proteoglycans and alter the structure of their HS components, but the nature of such structural alterations has not been characterized in detail. We analysed the effect of BFA on HS biosynthesis in Madin-Darby canine kidney (MDCK) cells, in which the Golgi complex is more resistant towards BFA than in most other cell types. We found that MDCK cells were able to secrete HS proteoglycans in spite of BFA treatment. However, the secretion of HS was reduced and the secreted HS differed from that produced by untreated cells. In BFA-treated cells, two structurally distinct pools of HS were generated. One pool was similar to HS from control cells, with the exception that the 6-O-sulphation of glucosamine (GlcN) residues was reduced. In contrast, the other pool consisted of largely unmodified N-acetylheparosan polymers with a low (<20%) proportion of N-sulphated GlcN residues but a substantial proportion of N-unsubstituted GlcN units, indicating that it had been acted upon by N-deacetylases and partly by the N-sulphotransferases, but not by O-sulphotransferases. Together, these findings represent a previously unrecognized alteration in HS biosynthesis caused by BFA, and differ dramatically from our previous findings in MDCK cells pertaining to the undersulphation of HS caused by sodium chlorate treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853543      PMCID: PMC1222395          DOI: 10.1042/0264-6021:3620359

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  ADP-ribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-COP to Golgi membranes.

Authors:  J G Donaldson; D Cassel; R A Kahn; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

2.  Effects of brefeldin A on the localization of chondroitin sulfate-synthesizing enzymes. Activities in subfractions of the Golgi from chick embryo epiphyseal cartilage.

Authors:  G Sugumaran; M Katsman; J E Silbert
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

3.  Differential effects of brefeldin A on sialylation of N- and O-linked oligosaccharides in low density lipoprotein receptor and epidermal growth factor receptor.

Authors:  S Shite; T Seguchi; H Mizoguchi; M Ono; M Kuwano
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

4.  Monensin and brefeldin A differentially affect the phosphorylation and sulfation of secretory proteins.

Authors:  P Rosa; S Mantovani; R Rosboch; W B Huttner
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

5.  Selective inhibition of transcytosis by brefeldin A in MDCK cells.

Authors:  W Hunziker; J A Whitney; I Mellman
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

6.  Effects of cycloheximide, brefeldin A, suramin, heparin and primaquine on proteoglycan and glycosaminoglycan biosynthesis in human embryonic skin fibroblasts.

Authors:  L A Fransson; P Karlsson; A Schmidtchen
Journal:  Biochim Biophys Acta       Date:  1992-11-17

7.  Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein.

Authors:  J G Donaldson; D Finazzi; R D Klausner
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

8.  PtK1 cells contain a nondiffusible, dominant factor that makes the Golgi apparatus resistant to brefeldin A.

Authors:  N T Ktistakis; M G Roth; G S Bloom
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

9.  Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A.

Authors:  R C Spiro; H H Freeze; D Sampath; J A Garcia
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

10.  Ricin transport in brefeldin A-treated cells: correlation between Golgi structure and toxic effect.

Authors:  K Sandvig; K Prydz; S H Hansen; B van Deurs
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  5 in total

Review 1.  Proteoglycan synthesis and Golgi organization in polarized epithelial cells.

Authors:  Gunnar Dick; Linn K Akslen-Hoel; Frøy Grøndahl; Ingrid Kjos; Kristian Prydz
Journal:  J Histochem Cytochem       Date:  2012-09-01       Impact factor: 2.479

Review 2.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

3.  Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.

Authors:  Jenny Presto; Maria Thuveson; Pernilla Carlsson; Marta Busse; Maria Wilén; Inger Eriksson; Marion Kusche-Gullberg; Lena Kjellén
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

4.  The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle.

Authors:  Marit Hjorth; Frode Norheim; Astri J Meen; Shirin Pourteymour; Sindre Lee; Torgeir Holen; Jørgen Jensen; Kåre I Birkeland; Vladimir N Martinov; Torgrim M Langleite; Kristin Eckardt; Christian A Drevon; Svein O Kolset
Journal:  Physiol Rep       Date:  2015-08

5.  Novel effects of Brefeldin A (BFA) in signaling through the insulin receptor (IR) pathway and regulating FoxO1-mediated transcription.

Authors:  Paulina Wyrozumska; Jason W Ashley; Sasanka Ramanadham; Qinglan Liu; W Timothy Garvey; Elizabeth Sztul
Journal:  Cell Logist       Date:  2014-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.